Navigation Links
Delcath Systems to Host Quarterly Update Conference Call
Date:12/30/2008

n be accessed via telephone; dial-in information will be provided a few days prior to the call.

About Delcath Systems, Inc.

Delcath Systems, Inc. is a medical technology company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of drug from entering the patient's bloodstream. The Company is currently enrolling patients in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. The Company's intellectual property portfolio consists of twenty-eight patents on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
2. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
3. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
4. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
5. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
6. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
7. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
8. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
9. Jon R. Wampler Joins Portico Systems Board of Directors
10. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
11. Portico Systems Wins Three Awards in 30 Days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014 Mental health issues affect ... break up families, ruin careers, and generally destroy ... those that suffer,” says Hardy Nutritionals® ... that our specialized nutritional treatments can reverse these ... “Mind Over Matter”, the premiere episode of O2 ...
(Date:11/24/2014)... 24, 2014 SafeHandles™ announced that they ... with Ed Begley Jr, airing via Discovery Channel. Dates ... provide a passive, non-invasive, replaceable, and affordable germ protective ... custom-fit shrinkable sleeves and adhesives to promote hand hygiene ... the core of SafeHandles is the desire to make ...
(Date:11/24/2014)... 24, 2014 Gersowitz Libo & Korek, P.C., ... received national Tier recognition in the 2015 Edition of U.S. ... ranking signals a unique combination of quality law practice and ... receive this honor and especially grateful to our clients whose ... and ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
(Date:11/23/2014)... a well-known wedding dress manufacturer, has unveiled its new collection ... now offered at deeply discounted prices, up to 75 percent ... 15. The main purpose of the promotion is to expand ... are ideal options for ladies who are eager to look ... new mint cocktail dresses are very beautiful; they are made ...
Breaking Medicine News(10 mins):Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2
... of ,Medicare for ... All, or Single-payer Healthcare, OAKLAND, Calif., May 1 With ... a new field poll,this week illustrates that Californians will once again ... registered,nurses., A poll this week by the influential Field Institute ...
... of high blood pressure-related deaths occur in poorer ... -- Roughly 80 percent of high blood pressure-related deaths ... study by New Zealand researchers shows. , Once regarded ... pressure is now a global problem that affects both ...
... (May 2, 2008) SAGE, the worlds fifth largest journals ... and the NASN Newsletter for the National Association of ... a forum for advancing the specialty of school nursing, ... the health of children in school. Published bi-monthly, it ...
... ... May 1 Cephalon, Inc. (Nasdaq:,CEPH) today reported first quarter ... for the first quarter 2007 and the company,s,sales guidance of ... quarter was $0.57. Excluding amortization expense and certain other,items, basic ...
... more likely to make up lost slumber during day ... with sleep problems, pain, diabetes and respiratory problems are ... U.S. study finds. , Researchers from Vanderbilt University Medical ... age 80.1 years, who were monitored for an average ...
... in the United States, Canada, Sweden, and Norway ... of insulin-producing islets in adults with difficult-to-control type ... the National Institutes of Health (NIH), will determine ... lead to improved, long-lasting control of blood glucose ...
Cached Medicine News:Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 2Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 3Health News:Hypertension Takes Huge Toll in Developing Countries 2Health News:The National Association of School Nurses selects SAGE to publish its journal 2Health News:Cephalon Reports Strong First Quarter Earnings 2Health News:Cephalon Reports Strong First Quarter Earnings 3Health News:Cephalon Reports Strong First Quarter Earnings 4Health News:Cephalon Reports Strong First Quarter Earnings 5Health News:Cephalon Reports Strong First Quarter Earnings 6Health News:Cephalon Reports Strong First Quarter Earnings 7Health News:Cephalon Reports Strong First Quarter Earnings 8Health News:Cephalon Reports Strong First Quarter Earnings 9Health News:Cephalon Reports Strong First Quarter Earnings 10Health News:Cephalon Reports Strong First Quarter Earnings 11Health News:Cephalon Reports Strong First Quarter Earnings 12Health News:Napping Habits Tied to Sleep Disorders 2Health News:Studies test new approaches to islet transplantation 2Health News:Studies test new approaches to islet transplantation 3Health News:Studies test new approaches to islet transplantation 4
(Date:11/23/2014)... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... President and Chief Executive Officer, will present a corporate ... Anthera will present at 4:30PM ET, ... New York City . ... a biopharmaceutical company focused on developing and commercializing products ...
(Date:11/22/2014)... Pennsylvania , 21 de noviembre de 2014 ... de ensayos clínicos externalizados y tecnologías eClinical, ha ... aproximación de ,seguimiento inteligente, para el seguimiento basado ... seguimiento inteligente amplía el concepto del seguimiento basado ... reducción de las visitas de seguimiento o cambio ...
(Date:11/22/2014)... Research and Markets  has announced the addition of the ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... market has been expanding rapidly owing to the improvement ... 2005-2013, sales of recombinant protein drugs available in Chinese ... it is projected that China ...
Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... A 9-year-old boy is now home safe and sound ... the way home from school thanks to the quick thinking ... device called EmSeeQ® by EmFinders that can quickly locate missing ... purchased the EmSeeQ bracelet in October for her son, Jakob, ...
... 2011 Generex Biotechnology Corporation (OTCBB: GNBT) ( ... into a binding letter agreement to license its ... Inc. ( www.amarantus.com ), a California-based biotechnology company, ... exchange for a non-refundable license fee of $10 ...
Cached Medicine Technology:EmSeeQ® Locator Device Aids in Returning Lost Spokane Boy with Autism Safely Back Home in Minutes 2EmSeeQ® Locator Device Aids in Returning Lost Spokane Boy with Autism Safely Back Home in Minutes 3Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 2Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 3Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 4Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins 5
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers....
Lyphochek Hypertension Markers Control is a trilevel control designed to monitor the performance of testing procedures for renin and other analytes associated with hypertension disorders....
... Plus Control is a liquid ... today's busy immunoassay laboratory. With ... human serum based control can ... control products for immunoassay and ...
The Acceava hCG Combo test provides superior performance for the diagnosis of pregnancy with a simple procedure that provides easy to read black on white results in 3 minutes for urine or 5 minutes f...
Medicine Products: